20
Participants
Start Date
September 9, 2019
Primary Completion Date
July 6, 2021
Study Completion Date
September 7, 2021
Pegloticase
intravenous (IV) infusion
Duke University Medical Center, Durham
Coastal Medical Research, Brunswick
Genesis Clinical Research, Tampa
University of Alabama Birmingham, Birmingham
Nephrology Consultants, Huntsville
Clear Lake Specialties, Webster
Keck School of Medicine of USC, Los Angeles
Amicis Research Center, Northridge
Lead Sponsor
Amgen
INDUSTRY